← Back to patent-cliff list
Metronidazole/Chlorhexidine Acetate/Borneol
Tier C — Watch / tradeMetronidazole/Chlorhexidine Acetate/Borneol
-
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：滴虫性阴道炎, Vaginitis
Regional status
US
-
EU
-
China
Approved
1996-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Metronidazole/Chlorhexidine Acetate/Borneol?
Approved indications include: 滴虫性阴道炎, Vaginitis.
When does the Metronidazole/Chlorhexidine Acetate/Borneol patent expire?
No public expiry year is available for Metronidazole/Chlorhexidine Acetate/Borneol yet; this page updates once verified.
How do I get a quote for Metronidazole/Chlorhexidine Acetate/Borneol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04